# AI-based Prediction of Prostate Cancer Metastasis Using Biopsy Pathology

> **NCT07660276** · — · ENROLLING_BY_INVITATION · sponsor: **Xiangya Hospital of Central South University** · enrollment: 3000 (estimated)

## Conditions studied

- Prostate Cancer Metastatic

## Interventions

- **OTHER:** Artificial Intelligence-Based Pathology Analysis

## Key facts

- **NCT ID:** NCT07660276
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-01-08
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2026-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07660276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07660276, "AI-based Prediction of Prostate Cancer Metastasis Using Biopsy Pathology". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07660276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*